Glioblastoma Research Organization Grant

Glioblastoma Research Organization Grant is sponsored by Glioblastoma Research Organization. The Glioblastoma Research Organization funds cutting-edge research projects globally to find a cure for Glioblastoma.

Our Projects — Glioblastoma Research Organization Our Cutting-Edge Projects to Help Find a Cure for Glioblastoma The Glioblastoma Research Organization (GBMRO) is a 501(c)(3) nonprofit organization raising awareness and funds for cutting-edge research to find a cure for Glioblastoma, a rare malignant, fast-growing tumor affecting the brain or spine.

The GBMRO was established in 2018 and, to date, has provided support to doctors and researchers through sixteen fully funded projects, donating over $725,000+ in the last few years. The GBMRO itself does not conduct research, however funds doctors and researchers that do so. Targeting RNA to Transform Glioblastoma Treatment MD Anderson Cancer Center is developing first‑of‑its‑kind RNA‑targeting therapies for glioblastoma (GBM).

By focusing on the powerful role of non‑coding RNAs, MD Anderson researchers are exploring a new therapeutic strategy that shows remarkable promise in patient‑derived tumor models and could pave the way for a new class of GBM treatments. Project MAP-GLIOMA utilises spatial biology to examine tumour samples in their natural state, preserving important characteristics often lost during traditional analysis methods.

Supported by a $50,000 Glioblastoma Research Organization grant, Project Kenny pioneers the first fully implantable, rechargeable Tumor Treating Fields (TTF) device aimed at delivering 24/7 therapy without external hardware.

Studies On Liquid Biopsy In Primary Brain Tumors The Brain Tumor Funders' Collaborative (BTFC) announced a request for proposals for two-year, $500,000 research grants for multi-institutional, multi-disciplinary research projects focusing on liquid biopsy for primary brain tumors.

Project Build On, a research initiative underway at The University of Texas MD Anderson Cancer Center, explores strategic ways to target metabolic weaknesses of glioblastoma. Through innovative drug combinations, researchers aim to block key pathways that fuel cancer growth, offering new hope for patients with this aggressive disease.

Marking the GBMRO'S first funded research project of 2025, Project Rocket, formally known as Characterizing Glioblastoma Progression, Pseudoprogression, and Radiation Necrosis with Bedside Ultrasound Using Sonolucent Cranial Implants, led by Dr. Randy S. D’Amico, aims to identify key ultrasound markers that reveal whether the tumor is growing, healing, or experiencing other changes.

The Glioblastoma Biobank Project The Glioblastoma Biobank Project, formally known as Key LARGO (Key Longitudinal Associations with Risk and Glioblastoma Outcomes), is now live and open for enrollment! The Glioblastoma Research Organization (GBMRO) announces its largest donation to date, $80,000, to fund Project DeLaRosa in partnership with Children's National Hospital.

Project Every Day Counts was launched with a $50,000 donation in collaboration with Gray for Glioblastoma Society to Children’s Hospital Los Angeles. The project honors Josh Wexler and the Wexler Family and their dedication to furthering GBM research. Project Garcia marks GBMRO’s fourth fully funded Glioblastoma research project and the first in collaboration with Sylvester Comprehensive Cancer Center in Miami, Florida.

The project includes novel research that uniquely applies a multiparametric intraoperative strategy to guide tumor resection and identify infiltrating tumor cells responsible for tumor recurrence. The median age for diagnosis of Glioblastoma is 65, with patient prognosis known to decline with increased age. Christopher Hine, Ph.

D. , a researcher in the Department of Cardiovascular and Metabolic Sciences at Cleveland Clinic's Lerner Research Institute, has a theory that could explain why. The Glioblastoma Research Organization's Project Rush is in collaboration with Lenox Hill Hospital’s Department of Neurosurgery’s Brain Tumor Center in New York City.

Project Rush was inspired by the passing of Neil Peart a Canadian-American musician, best known as the drummer and lyricist of the rock band, Rush. Funded by the Glioblastoma Research Organization, the laboratory of Dr. Steven Millward at the University of Texas MD Anderson Cancer Center has launched The Lee Project, which focuses on the directed evolution of vectors for treating GBM.

Brain tumors are the leading cause of cancer-related death in children. Of all the pediatric brain tumors, high-grade gliomas (HGG) remain the greatest challenge, with few treatment options available and a five-year survival rate of only 10-30 percent. A potential alternative to conventional treatments is to utilize a patient’s own immune system to attack tumor cells—immunotherapy.

The stories driving our research-funding mission. The stories driving our research-funding mission. The Warrior Wall by the Glioblastoma Research Organization was created to honor all Glioblastoma Warriors - throughout all stages of their journey.

The Warrior Wall was designed to not only commemorate the lives of those lost to Glioblastoma, but to empower and give strength to those currently receiving treatment, those monitoring symptoms, and those in remission - to show that we are never alone in this process. Looking for funding for your next Glioblastoma project? Together, we will find a cure.